Cervical Lymphadenopathies as Unusual Presentations of Erdheim–Chester Disease: The Need for Knowledge for Diagnosis and Treatment

The appearance of cervical adenopathies can occur in many pathologies in a non-specific manner; Erdheim–Chester disease (ECD) is characterized by xanthogranulomatous and xanthomatous infiltration of different tissues with numerous foamy histiocytes. Bone lesions are frequent and radiological feature...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Raúl Antúnez-Conde, Carlos Navarro Cuéllar, Santiago Ochandiano, Alberto Díez-Montiel, Pablo Montes, Eduardo Monteserín, Marc Agea, Dafne Gascón, Ignacio Navarro, Gema Arenas, Manuel Tousidonis, José Ignacio Salmerón
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/cda845d2f4c3443a800203d5f9dcab5d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cda845d2f4c3443a800203d5f9dcab5d
record_format dspace
spelling oai:doaj.org-article:cda845d2f4c3443a800203d5f9dcab5d2021-11-25T18:10:24ZCervical Lymphadenopathies as Unusual Presentations of Erdheim–Chester Disease: The Need for Knowledge for Diagnosis and Treatment10.3390/life111111162075-1729https://doaj.org/article/cda845d2f4c3443a800203d5f9dcab5d2021-10-01T00:00:00Zhttps://www.mdpi.com/2075-1729/11/11/1116https://doaj.org/toc/2075-1729The appearance of cervical adenopathies can occur in many pathologies in a non-specific manner; Erdheim–Chester disease (ECD) is characterized by xanthogranulomatous and xanthomatous infiltration of different tissues with numerous foamy histiocytes. Bone lesions are frequent and radiological features are pathognomonic for diagnosis, but lymph node involvement is exceptional and is not a form of presentation reported in the literature. Recurrent BRAFV600E mutation and others have been discovered in recent years. Since then, several treatments targeting the BRAF and MEK pathways have been developed with high success rates; even so, interferon-α continues to be one of the most widely used treatments. The best imaging test for the study and monitoring of the disease is PET-CT. The prognosis of ECD is relatively poor, with a survival of 43% of patients after 32 months follow-up. Higher survival rates have been reported in patients treated with interferon. The authors present an exceptional case of ECD with cervical adenopathies as a debut, highlighting the need for the knowledge of the disease for differential diagnosis, early treatment, and the importance of communication between the clinician and the pathologist. The main features of the disease and a brief discussion of current diagnosis and treatment are reviewed.Raúl Antúnez-CondeCarlos Navarro CuéllarSantiago OchandianoAlberto Díez-MontielPablo MontesEduardo MonteserínMarc AgeaDafne GascónIgnacio NavarroGema ArenasManuel TousidonisJosé Ignacio SalmerónMDPI AGarticleimmunohistochemistrylymph nodeshead and neckimage-guided biopsyScienceQENLife, Vol 11, Iss 1116, p 1116 (2021)
institution DOAJ
collection DOAJ
language EN
topic immunohistochemistry
lymph nodes
head and neck
image-guided biopsy
Science
Q
spellingShingle immunohistochemistry
lymph nodes
head and neck
image-guided biopsy
Science
Q
Raúl Antúnez-Conde
Carlos Navarro Cuéllar
Santiago Ochandiano
Alberto Díez-Montiel
Pablo Montes
Eduardo Monteserín
Marc Agea
Dafne Gascón
Ignacio Navarro
Gema Arenas
Manuel Tousidonis
José Ignacio Salmerón
Cervical Lymphadenopathies as Unusual Presentations of Erdheim–Chester Disease: The Need for Knowledge for Diagnosis and Treatment
description The appearance of cervical adenopathies can occur in many pathologies in a non-specific manner; Erdheim–Chester disease (ECD) is characterized by xanthogranulomatous and xanthomatous infiltration of different tissues with numerous foamy histiocytes. Bone lesions are frequent and radiological features are pathognomonic for diagnosis, but lymph node involvement is exceptional and is not a form of presentation reported in the literature. Recurrent BRAFV600E mutation and others have been discovered in recent years. Since then, several treatments targeting the BRAF and MEK pathways have been developed with high success rates; even so, interferon-α continues to be one of the most widely used treatments. The best imaging test for the study and monitoring of the disease is PET-CT. The prognosis of ECD is relatively poor, with a survival of 43% of patients after 32 months follow-up. Higher survival rates have been reported in patients treated with interferon. The authors present an exceptional case of ECD with cervical adenopathies as a debut, highlighting the need for the knowledge of the disease for differential diagnosis, early treatment, and the importance of communication between the clinician and the pathologist. The main features of the disease and a brief discussion of current diagnosis and treatment are reviewed.
format article
author Raúl Antúnez-Conde
Carlos Navarro Cuéllar
Santiago Ochandiano
Alberto Díez-Montiel
Pablo Montes
Eduardo Monteserín
Marc Agea
Dafne Gascón
Ignacio Navarro
Gema Arenas
Manuel Tousidonis
José Ignacio Salmerón
author_facet Raúl Antúnez-Conde
Carlos Navarro Cuéllar
Santiago Ochandiano
Alberto Díez-Montiel
Pablo Montes
Eduardo Monteserín
Marc Agea
Dafne Gascón
Ignacio Navarro
Gema Arenas
Manuel Tousidonis
José Ignacio Salmerón
author_sort Raúl Antúnez-Conde
title Cervical Lymphadenopathies as Unusual Presentations of Erdheim–Chester Disease: The Need for Knowledge for Diagnosis and Treatment
title_short Cervical Lymphadenopathies as Unusual Presentations of Erdheim–Chester Disease: The Need for Knowledge for Diagnosis and Treatment
title_full Cervical Lymphadenopathies as Unusual Presentations of Erdheim–Chester Disease: The Need for Knowledge for Diagnosis and Treatment
title_fullStr Cervical Lymphadenopathies as Unusual Presentations of Erdheim–Chester Disease: The Need for Knowledge for Diagnosis and Treatment
title_full_unstemmed Cervical Lymphadenopathies as Unusual Presentations of Erdheim–Chester Disease: The Need for Knowledge for Diagnosis and Treatment
title_sort cervical lymphadenopathies as unusual presentations of erdheim–chester disease: the need for knowledge for diagnosis and treatment
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/cda845d2f4c3443a800203d5f9dcab5d
work_keys_str_mv AT raulantunezconde cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT carlosnavarrocuellar cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT santiagoochandiano cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT albertodiezmontiel cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT pablomontes cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT eduardomonteserin cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT marcagea cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT dafnegascon cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT ignacionavarro cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT gemaarenas cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT manueltousidonis cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
AT joseignaciosalmeron cervicallymphadenopathiesasunusualpresentationsoferdheimchesterdiseasetheneedforknowledgefordiagnosisandtreatment
_version_ 1718411525556797440